Athira cited altered research in $15 million NIH grant application

Table of Contents1 What is it?2 What is integrated? Biotech business Athira Pharma, which is

Biotech business Athira Pharma, which is in turmoil immediately after its main executive was identified to have revealed investigation containing altered photographs, now faces a new issue: It cited the allegedly doctored papers in a federal grant software. This results in the likely for the governing administration or whistleblowers to go after lawful action to pressure the company to repay not only the $15 million it obtained to fund its function but also additional penalties.

Three altered papers co-authored by previous chief executive Leen Kawas — who has been positioned on depart — were being referenced in an Athira application for funding from the Nationwide Institutes of Well being, which STAT received through a Liberty of Info Act ask for. This tends to make the Seattle-centered company likely liable for Fake Claims Act damages, in accordance to two lawful specialists, that means Athira could be on the hook for three occasions the grant resources, or $45 million.

Unlock this posting by subscribing to STAT+ and take pleasure in your initially 30 times free!

GET Started